Developmental Potential of Abnormally Fertilized Oocytes and the Associated Clinical Outcomes
- PMID: 33250770
- PMCID: PMC7672117
- DOI: 10.3389/fphys.2020.528424
Developmental Potential of Abnormally Fertilized Oocytes and the Associated Clinical Outcomes
Abstract
This study aims to investigate the embryo development potential of extending the culture of abnormally fertilized zygotes with no pronuclear (0PN), monopronuclear (1PN), and poor-quality day 3 embryos and to determine the associated clinical outcomes. This is a retrospective study performed between January 2014 and May 2018 at Jinhua People's Hospital. The normal developed embryos and the abnormal 0PN, 1PN, and poor-quality day 3 embryos were cultured to day 5 or 6 for embryo transfer. Clinical outcomes resulting from abnormal embryos and normally developed embryos were compared. A total of 6466 embryos (1542 0PN, 852 1PN, and 4072 poor-quality day 3 embryos) from 831 treatment cycles were cultured to the blastocyst stage. The total blastulation rate was 17.3% (1121/6466) with 18.2% in 0PN, 26.1% in 1PN, and 15.2% in poor-quality day 3 embryos. The rate for good-quality blastocyst formation was 9.5% (616/6466) with 11.2% in 0PN group, 14.8% in 1PN group, and 7.8% in poor-quality day 3 embryos, respectively. Blastulation rates of 0PN and 1PN derived from intracytoplasmic sperm injection (ICSI) were significantly lower compared with the in vitro fertilization group. A total of 243 cycles were transferred with blastocysts originating from abnormal embryos, resulting in 109 (44.9%) clinical pregnancies and 19 (17.4%) miscarriages; in the control group, a total of 350 cycles resulted in 214 (61.1%) clinical pregnancies and 18 (8.4%) miscarriages. The live birth rate was significantly lower in the abnormal embryo group than that in the control group. Collectively, conventional in vitro fertilization derived 0PN and 1PN zygotes, not ICSI, together with day 3 embryos with poor quality, that were able to reach the blastocyst stage and produce a fair pregnancy rate and live birth rate.
Keywords: blastocyst; discarded embryo; extending culture; monopronuclear; pregnant rate.
Copyright © 2020 Chen, Shi, Mao, Zou and Yu.
Figures
Similar articles
-
Clinical outcomes of frozen-thawed blastocysts from zygotes with no or one pronucleus for in vitro fertilization and intracytoplasmic sperm injection cycles.Arch Gynecol Obstet. 2023 Sep;308(3):1015-1022. doi: 10.1007/s00404-023-07118-1. Epub 2023 Jun 30. Arch Gynecol Obstet. 2023. PMID: 37391645 Free PMC article.
-
Clinical outcomes of transfer of frozen and thawed single blastocysts derived from nonpronuclear and monopronuclear zygotes.Reprod Med Biol. 2019 May 15;18(3):278-283. doi: 10.1002/rmb2.12275. eCollection 2019 Jul. Reprod Med Biol. 2019. PMID: 31312107 Free PMC article.
-
The use of blastocysts developing from nonpronuclear and monopronuclear zygotes can be considered in PGT-SR: a retrospective cohort study.BMC Pregnancy Childbirth. 2025 May 3;25(1):530. doi: 10.1186/s12884-025-07621-0. BMC Pregnancy Childbirth. 2025. PMID: 40319238 Free PMC article.
-
Could blastocysts derived from abnormal fertilized zygotes be used? A systematic review and meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2025 Jul;311:114033. doi: 10.1016/j.ejogrb.2025.114033. Epub 2025 May 20. Eur J Obstet Gynecol Reprod Biol. 2025. PMID: 40490324 Review.
-
What happens to abnormally fertilized embryos? A scoping review.Reprod Biomed Online. 2023 May;46(5):802-807. doi: 10.1016/j.rbmo.2023.02.005. Epub 2023 Feb 22. Reprod Biomed Online. 2023. PMID: 36997399
Cited by
-
The Identification of Molecular Ploidy Status of Abnormal Pronuclear Zygotes Reveals a Significant Number of Euploid Blastocysts Available for Conception.Biomedicines. 2024 Dec 28;13(1):51. doi: 10.3390/biomedicines13010051. Biomedicines. 2024. PMID: 39857635 Free PMC article.
-
Developmental potential of zygotes without pronucleus (0PN) and pregnancy outcomes after single euploid blastocyst transfers.J Assist Reprod Genet. 2025 Apr;42(4):1309-1316. doi: 10.1007/s10815-025-03430-8. Epub 2025 Feb 21. J Assist Reprod Genet. 2025. PMID: 39984800
-
Time-lapse monitoring of fertilized human oocytes focused on the incidence of 0PN embryos in conventional in vitro fertilization cycles.Sci Rep. 2021 Sep 22;11(1):18862. doi: 10.1038/s41598-021-98312-1. Sci Rep. 2021. PMID: 34552114 Free PMC article.
-
Advanced age woman with diminished ovarian reserve obtained live birth following a zero pronuclei-derived four-cell frozen-thawed embryo transfer on day 4: a case report.Front Med (Lausanne). 2024 Sep 24;11:1462425. doi: 10.3389/fmed.2024.1462425. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39380739 Free PMC article.
-
Developmental potential of non- and mono-pronuclear zygotes and associated clinical outcomes in IVF cycles.Front Endocrinol (Lausanne). 2024 Mar 12;15:1361734. doi: 10.3389/fendo.2024.1361734. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38532894 Free PMC article.
References
-
- Bodri D., Sugimoto T., Serna J. Y., Kondo M., Kato R., Kawachiya S., et al. (2015). Influence of different oocyte insemination techniques on early and late morphokinetic parameters: retrospective analysis of 500 time-lapse monitored blastocysts. Fertil. Steril. 104 1175–1181. 10.1016/j.fertnstert.2015.07.1164 - DOI - PubMed
-
- Bonduelle M., Wennerholm U. B., Loft A., Tarlatzis B. C., Peters C., Henriet S., et al. (2005). A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception. Hum. Reprod. 20 413–419. 10.1093/humrep/deh592 - DOI - PubMed
-
- Bradley C. K., Traversa M. V., Hobson N., Gee A. J., Mcarthur S. J. (2017). Clinical use of monopronucleated zygotes following blastocyst culture and preimplantation genetic screening, including verification of biparental chromosome inheritance. Reprod. Biomed. 34 567–574. 10.1016/j.rbmo.2017.03.013 - DOI - PubMed
LinkOut - more resources
Full Text Sources